IRSA Inversiones y (NYSE:IRS) Azioni

IRSA Inversiones y

IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segment includes Shopping Malls; Offices; Sales and Developments; Hotels and others. It generates maximum revenue from the Shopping Malls segment. The Shopping Malls segment comprised of lease and service revenues related to rental of commercial space and other spaces in the shopping malls of the company.

IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of Common Stock)

IRSA Inversiones y Representaciones SA

IRSA Inversiones Y Representaciones S.A. Warrants to purchase Common Shares

IRESS Ltd

News

IRSA Inversiones Says Revenues For Six Months Ending Dec. 31 Totals ARS212.14M, Lower Than ARS220.936M YoY

WIIM

ARGT

BBAR

CEPU

CRESY

GGAL

LOMA

MELI

SUPV

Telecom Argentina Stet - France Telecom S.A.

Shares of US-listed Argentine stocks are trading higher on continued strength after the nation received a credit upgrade from Fitch over the weekend.

IRSA Inversiones y (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IRS#NYSE">IRS</a>) reported quarterly losses of $(0.15) per share. This is a 104.61 percent decrease over earnings of $3.36 per share from the same period last year. The company reported $95.62 million in sales this quarter. This is a 4.36 percent decrease over sales of $99.98 million the same period last year.

Earnings

IRSA Inversiones y Q1 EPS $(0.15) Down From $3.36 YoY, Sales $95.62M Down From $99.98M YoY

DESP

Shares of US-listed Argentine stocks are trading higher after Donald Trump's presidential victory.

BIOX

Shares of US-listed Argentine stocks are trading higher after Banco de la Nacion, the country's largest bank, stated it wants to issue debt and return to international capital markets for the first time in 30 years.

HIGHLIGHTS
<ul>
<li>The rental adjusted EBITDA reached&nbsp;ARS 171,772 million, 8.8% higher than in 2023, driven by the Shopping Centers and Hotels segments.</li>
<li>The net result for fiscal year 2024 recorded a loss of&nbsp;ARS 23,054 million due mainly to the negative result due to changes in the fair value of investment properties.</li>
<li>Real tenant sales in Shopping Centers fell 4.5% in fiscal year 2024 compared to 2023 due to a first semester of growth and a second semester of contraction in economic activity. Occupancy remained high at 97.4%.</li>
<li>During the year we sold 3 floors of the "200 Della&nbsp;Paolera" building, the Suipacha 652/64 building, our 50% stake in Quality Invest S.A, owner of the San Martín property, and we bartered the Ezpeleta property in the district of Quilmes, Buenos Aires province. On the other hand, we signed a management trust contract at cost for the residential development of the "Del Plata" building, located in the heart of downtown Buenos Aires.</li>
<li>Subsequently, we acquired a property next to Alto&nbsp;Avellaneda shopping mall, with a built area of 32,660 sqm and potential for future expansion, and we launched an ambitious plan to develop residential projects in Argentina, among which Ramblas del Plata in Puerto Madero Sur stands out, formerly known as Costa Urbana.&nbsp;</li>
<li>We distributed dividends twice during the fiscal year for a total amount of&nbsp;ARS 119,000 million and repurchased our own shares to date for approximately 4.0% of the share capital, having invested ARS 29,674 million.</li>
</ul>
Financial Highlights (In millions of Argentine Pesos) FY 2024
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">Income Statement</td>
<td colspan="1" rowspan="1">06/30/2024</td>
<td colspan="1" rowspan="1">06/30/2023</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Revenues</td>
<td colspan="1" rowspan="1">328,546</td>
<td colspan="1" rowspan="1">331,721</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Consolidated Gross Profit</td>
<td colspan="1" rowspan="1">219,305</td>
<td colspan="1" rowspan="1">217,276</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Net result from changes in the fair value of investment properties</td>
<td colspan="1" rowspan="1">(350,591)</td>
<td colspan="1" rowspan="1">(182,590)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Consolidated Result from Operations</td>
<td colspan="1" rowspan="1">(190,695)</td>
<td colspan="1" rowspan="1">(97,115)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Result for the Period</td>
<td colspan="1" rowspan="1">(23,054)</td>
<td colspan="1" rowspan="1">215,837</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Attributable to:</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">IRSA's Shareholders</td>
<td colspan="1" rowspan="1">(18,377)</td>
<td colspan="1" rowspan="1">213,076</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Non-Controlling interest</td>
<td colspan="1" rowspan="1">(4,677)</td>
<td colspan="1" rowspan="1">2,761</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">EPS (Basic)</td>
<td colspan="1" rowspan="1">(24.77)</td>
<td colspan="1" rowspan="1">284.86</td>
</tr>
<tr>
<td colspan="1" rowspan="1">EPS (Diluted)</td>
<td colspan="1" rowspan="1">(24.77)</td>
<td colspan="1" rowspan="1">259.85</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Balance Sheet</td>
<td colspan="1" rowspan="1">06/30/2024</td>
<td colspan="1" rowspan="1">06/30/2023</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Current Assets</td>
<td colspan="1" rowspan="1">227,724</td>
<td colspan="1" rowspan="1">260,910</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Non-Current Assets</td>
<td colspan="1" rowspan="1">2,014,041</td>
<td colspan="1" rowspan="1">2,382,939</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Total Assets</td>
<td colspan="1" rowspan="1">2,241,765</td>
<td colspan="1" rowspan="1">2,643,849</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Current Liabilities</td>
<td colspan="1" rowspan="1">274,913</td>
<td colspan="1" rowspan="1">281,329</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Non-Current Liabilities</td>
<td colspan="1" rowspan="1">814,415</td>
<td colspan="1" rowspan="1">934,425</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Total Liabilities</td>
<td colspan="1" rowspan="1">1,089,328</td>
<td colspan="1" rowspan="1">1,215,754</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Non-Controlling Interest</td>
<td colspan="1" rowspan="1">73,792</td>
<td colspan="1" rowspan="1">82,965</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Shareholders' Equity</td>
<td colspan="1" rowspan="1">1,152,437</td>
<td colspan="1" rowspan="1">1,428,095</td>
</tr>
</tbody>
</table>
</figure>

IRSA Inversiones Y Representaciones S.A. EPS ARS(24.77) Down From ARS259.85 YoY; Revenues ARS328.546 Million Down From ARS331.721 Million YoY

IRSA shares are trading higher after Jefferies upgraded the stock from Hold to Buy and raised its price target from $10.5 to $13.

Jefferies analyst Pedro Baptista upgrades IRSA Inversiones y (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IRS#NYSE">IRS</a>) from Hold to Buy and raises the price target from $10.5 to $13.

Upgrades

Price Target

Analyst Ratings

Jefferies Upgrades IRSA Inversiones y to Buy, Raises Price Target to $13

IRSA Inversiones y (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IRS#NYSE">IRS</a>) reported quarterly losses of $(0.59) per share. This is a 164.13 percent decrease over earnings of $0.92 per share from the same period last year. The company reported $134.53 million in sales this quarter. This is a 12.06 percent increase over sales of $120.06 million the same period last year.

IRSA Inversiones y Q3 EPS $(0.59) Down From $0.92 YoY, Sales $134.53M Up From $120.06M YoY

IRSA Inversiones y (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IRS#NYSE">IRS</a>) reported quarterly earnings of $0.77 per share. This is a 76400 percent increase over earnings of $0.00 per share from the same period last year. The company reported $132.42 million in sales this quarter. This is a 11.19 percent increase over sales of $119.09 million the same period last year.

IRSA Inversiones y Q2 EPS $0.77 Up From $0.00 YoY, Sales $132.42M Up From $119.09M YoY

<h3>Companies Reporting Before The Bell</h3>
&bull; NAPCO Security Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSSC#NASDAQ">NSSC</a>) is estimated to report quarterly earnings at $0.26 per share on revenue of $43.92 million.
&bull; Affiliated Managers Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMG#NYSE">AMG</a>) is projected to report quarterly earnings at $5.98 per share on revenue of $524.15 million.
&bull; Sphere Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPHR#NYSE">SPHR</a>) is expected to report quarterly loss at $0.85 per share on revenue of $300.23 million.
&bull; Bowlero (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOWL#NYSE">BOWL</a>) is estimated to report quarterly earnings at $0.12 per share on revenue of $300.52 million.
&bull; ON Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) is estimated to report quarterly earnings at $1.21 per share on revenue of $2.00 billion.
&bull; Tyson Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSN#NYSE">TSN</a>) is likely to report quarterly earnings at $0.40 per share on revenue of $13.36 billion.
&bull; McDonald&#39;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) is likely to report quarterly earnings at $2.82 per share on revenue of $6.45 billion.
&bull; Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) is expected to report quarterly earnings at $0.55 per share on revenue of $4.20 billion.
&bull; IDEXX Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDXX#NASDAQ">IDXX</a>) is expected to report quarterly earnings at $2.11 per share on revenue of $889.85 million.
&bull; Caterpillar (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAT#NYSE">CAT</a>) is projected to report quarterly earnings at $4.75 per share on revenue of $17.11 billion.
&bull; Graham (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GHM#NYSE">GHM</a>) is projected to report quarterly loss at $0.03 per share on revenue of $38.94 million.
&bull; CNA Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNA#NYSE">CNA</a>) is likely to report quarterly earnings at $1.10 per share on revenue of $2.95 billion.
&bull; Mitsubishi UFJ Finl Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MUFG#NYSE">MUFG</a>) is projected to report earnings for its third quarter.
&bull; Timken (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TKR#NYSE">TKR</a>) is estimated to report quarterly earnings at $1.22 per share on revenue of $1.06 billion.
&bull; Loews (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/L#NYSE">L</a>) is likely to report earnings for its fourth quarter.
&bull; Mesa Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLAB#NASDAQ">MLAB</a>) is likely to report quarterly earnings at $0.19 per share on revenue of $54.89 million.
&bull; Air Products &amp; Chemicals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APD#NYSE">APD</a>) is expected to report quarterly earnings at $3.00 per share on revenue of $3.20 billion.
<h3>Companies Reporting After The Bell</h3>
&bull; Bright Scholar Education (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEDU#NYSE">BEDU</a>) is projected to report earnings for its first quarter.
&bull; IRSA Inversiones y (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IRS#NYSE">IRS</a>) is estimated to report earnings for its second quarter.
&bull; Kilroy Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRC#NYSE">KRC</a>) is projected to report earnings for its fourth quarter.
&bull; BellRing Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRBR#NYSE">BRBR</a>) is estimated to report quarterly earnings at $0.39 per share on revenue of $412.86 million.
&bull; Hillenbrand (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HI#NYSE">HI</a>) is expected to report quarterly earnings at $0.68 per share on revenue of $777.81 million.
&bull; NXP Semiconductors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) is estimated to report quarterly earnings at $3.63 per share on revenue of $3.40 billion.
&bull; Symbotic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) is likely to report quarterly loss at $0.06 per share on revenue of $368.89 million.
&bull; Golub Capital BDC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GBDC#NASDAQ">GBDC</a>) is likely to report quarterly earnings at $0.48 per share on revenue of $160.51 million.
&bull; Kforce (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KFRC#NASDAQ">KFRC</a>) is projected to report quarterly earnings at $0.79 per share on revenue of $363.36 million.
&bull; Vertex Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) is estimated to report quarterly earnings at $4.09 per share on revenue of $2.51 billion.
&bull; Itau Unibanco Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITUB#NYSE">ITUB</a>) is estimated to report quarterly earnings at $0.19 per share on revenue of $7.99 billion.
&bull; United States Steel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>) is projected to report quarterly earnings at $0.37 per share on revenue of $299.98 million.
&bull; Palantir Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) is expected to report quarterly earnings at $0.07 per share on revenue of $602.55 million.
&bull; Skyline Champion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKY#NYSE">SKY</a>) is estimated to report quarterly earnings at $0.64 per share on revenue of $499.72 million.
&bull; AECOM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACM#NYSE">ACM</a>) is likely to report quarterly earnings at $0.95 per share on revenue of $3.66 billion.
&bull; Amkor Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>) is expected to report quarterly earnings at $0.41 per share on revenue of $1.68 billion.
&bull; Coherent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) is likely to report quarterly earnings at $0.26 per share on revenue of $1.12 billion.
&bull; Simpson Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSD#NYSE">SSD</a>) is estimated to report quarterly earnings at $1.48 per share on revenue of $482.21 million.
&bull; Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) is projected to report quarterly earnings at $2.03 per share on revenue of $693.15 million.
&bull; Kimball Electronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KE#NASDAQ">KE</a>) is estimated to report quarterly earnings at $0.44 per share on revenue of $435.67 million.
&bull; Cabot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBT#NYSE">CBT</a>) is likely to report quarterly earnings at $1.49 per share on revenue of $952.85 million.
&bull; ChampionX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHX#NASDAQ">CHX</a>) is likely to report quarterly earnings at $0.44 per share on revenue of $950.17 million.
&bull; Crown Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCK#NYSE">CCK</a>) is estimated to report quarterly earnings at $1.43 per share on revenue of $2.95 billion.
&bull; Flexsteel Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLXS#NASDAQ">FLXS</a>) is likely to report quarterly earnings at $0.56 per share on revenue of $102.12 million.
&bull; Gladstone Cap (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLAD#NASDAQ">GLAD</a>) is projected to report quarterly earnings at $0.28 per share on revenue of $23.39 million.
&bull; Rambus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) is estimated to report quarterly earnings at $0.45 per share on revenue of $134.00 million.
&bull; Chegg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHGG#NYSE">CHGG</a>) is estimated to report quarterly earnings at $0.36 per share on revenue of $187.44 million.
&bull; Simon Property Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPG#NYSE">SPG</a>) is estimated to report earnings for its fourth quarter.
&bull; Varonis Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNS#NASDAQ">VRNS</a>) is estimated to report quarterly earnings at $0.23 per share on revenue of $151.88 million.
&bull; Intevac (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVAC#NASDAQ">IVAC</a>) is estimated to report quarterly loss at $0.12 per share on revenue of $9.70 million.
&bull; FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) is estimated to report quarterly earnings at $1.08 per share on revenue of $1.25 billion.
&bull; J&amp;J Snack Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JJSF#NASDAQ">JJSF</a>) is expected to report quarterly earnings at $0.78 per share on revenue of $362.88 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

AMKR

BEDU

BOWL

BRBR

CHGG

COHR

FLXS

GBDC

GLAD

IDXX

ITUB

IVAC

JJSF

KFRC

MLAB

MUFG

NSSC

NXPI

PLTR

RMBS

SPHR

VRNS

VRTX

Earnings Scheduled For February 5, 2024

<h3>Understanding Value Stocks</h3>
A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued. 
<h2>Below is a list of notable value stocks in the real estate sector:</h2>
<ol>
<li>Five Point Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FPH#NYSE">FPH</a>) - P/E: 4.41</li>
<li>Seven Hills Realty Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEVN#NASDAQ">SEVN</a>) - P/E: 7.39</li>
<li>Ready Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RC#NYSE">RC</a>) - P/E: 4.18</li>
<li>Rithm Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RITM#NYSE">RITM</a>) - P/E: 7.58</li>
<li>IRSA Inversiones y (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IRS#NYSE">IRS</a>) - P/E: 3.71</li>
</ol>
This quarter, Five Point Holdings experienced an increase in earnings per share, which was $0.09 in Q3 and is now $0.39. Seven Hills Realty Trust has reported Q3 earnings per share at $0.36, which has decreased by 2.7% compared to Q2, which was 0.37. Its most recent dividend yield is at 10.27%, which has decreased by 2.85% from 13.12% in the previous quarter.
Most recently, Ready Capital reported earnings per share at $0.28, whereas in Q2 earnings per share sat at $0.35. Most recently, the company reported a dividend yield of 10.7%, which has decreased by 2.34% from last quarter's yield of 13.04%.
This quarter, Rithm Capital experienced a decrease in earnings per share, which was $0.62 in Q2 and is now $0.58. Most recently, the company reported a dividend yield of 9.6%, which has decreased by 0.45% from last quarter's yield of 10.05%.
IRSA Inversiones y has reported Q1 earnings per share at $3.36, which has increased by 143.48% compared to Q4, which was 1.38. 
These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.

RITM

SEVN

Overview Of Value Stocks In The Real Estate Sector

Shares of Anavex Life Sciences Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avxl#NASDAQ">AVXL</a>) moved lower during Monday&rsquo;s session after the company reported fourth-quarter financial results.
The company posted a quarterly net loss of $10.1 million, inclusive of $3.2 million in non-cash items, or 12 cents per share for the fourth quarter, versus a year-ago net loss of $14.3 million, inclusive of $6.0 million in non-cash items, or 18 cents per share for the year-ago period.
Anavex Life Sciences shares fell 10% to $6.35 on Monday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>RedHill Biopharma Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdhl#NASDAQ">RDHL</a>) shares climbed 125% to $0.7063 after the company announced the FDA has granted five years&#39; market exclusivity for Talicia.</li>
<li>Biodexa Pharmaceuticals Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bdrx#NASDAQ">BDRX</a>) gained 122.8% to $5.96 after the company announced it entered into agreements to acquire an exclusive worldwide license to tolimidone.</li>
<li>Tharimmune, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/thar#NASDAQ">THAR</a>) shares climbed 48.6% to $4.28 after the company reported Phase 1 data on TH104 for chronic pruritis in primary biliary cholangitis.</li>
<li>Asset Entities Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asst#NASDAQ">ASST</a>) gained 34% to $0.4703 after the company announced a stock repurchase program.</li>
<li>Captivision Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/capt#NASDAQ">CAPT</a>) rose 20.1% to $2.81 after surging 44% on Friday.</li>
<li>Perfect Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/perf#NYSE">PERF</a>) climbed 19.7% to $2.9944. The company on Monday announced the commencement of a tender offer to purchase shares above the current share price.</li>
<li>IO Biotech, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iobt#NASDAQ">IOBT</a>) gained 19% to $1.3988. IO Biotech Chief Accounting Officer Brian Burkavage acquired a total of 10,000 shares at an average price of $1.01.</li>
<li>TC Biopharm (Holdings) Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcbp#NASDAQ">TCBP</a>) gained 18.4% to $0.6680 after the company announced FDA clearance of the Phase 1B IND for TCB-008 in Acute Myeloid Leukemia.</li>
<li>Apollomics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aplm#NASDAQ">APLM</a>) shares rose 18.3% to $1.1750 after surging 14% on Friday. The company&rsquo;s partner in China, Avistone Biotechnology Co. Ltd., recently received conditional approval from the National Medical Products Administration (NMPA) of China for the commercialization of vebreltinib to treat patients with MET exon 14 skipping non-small cell lung cancer (NSCLC).</li>
<li>Safety Shot, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/shot#NASDAQ">SHOT</a>) gained 17.8% to $4.2782.</li>
<li>ClearSign Technologies Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clir#NASDAQ">CLIR</a>) gained 16% to $1.5665.</li>
<li>Affirm Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/afrm#NASDAQ">AFRM</a>) jumped 13.7% to $29.82 following reports of record &#39;buy now, pay later&#39; predictions on Cyber Monday.</li>
<li>MIRA Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mira#NASDAQ">MIRA</a>) rose 13% to $3.72.</li>
<li>Oxbridge Re Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/oxbr#NASDAQ">OXBR</a>) gained 12.5% to $1.2156.</li>
<li>IRSA Inversiones y Representaciones Sociedad An&oacute;nima (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/irs#NYSE">IRS</a>) rose 12.4% to $9.13.</li>
<li>EHang Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eh#NASDAQ">EH</a>) gained 12.1% to $19.71.</li>
<li>Ituran Location and Control Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/itrn#NASDAQ">ITRN</a>) climbed 11.3% to $27.69 after the company reported third-quarter financial results.</li>
<li>Xenon Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xene#NASDAQ">XENE</a>) rose 10.2% to $31.93 after the company announced topline results from the Phase 2 proof-of-concept X-NOVA clinical trial of XEN1101 in MDD.</li>
<li>Applied Optoelectronics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aaoi#NASDAQ">AAOI</a>) gained 8.8% to $14.19.</li>
<li>Telecom Argentina S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/teo#NYSE">TEO</a>) rose 6.7% to $8.26.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>10X Capital Venture Acquisition Corp. II (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vcxa#NASDAQ">VCXA</a>) shares dipped 21.2% to $8.39.</li>
<li>BioNexus Gene Lab Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bglc#NASDAQ">BGLC</a>) fell 19.5% to $0.7246 after jumping 144% on Friday.</li>
<li>HCW Biologics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcwb#NASDAQ">HCWB</a>) declined 14.5% to $1.00.</li>
<li>SharpLink Gaming Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sbet#NASDAQ">SBET</a>) fell 14.4% to $1.49.</li>
<li>Innodata Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inod#NASDAQ">INOD</a>) fell 14.2% to $5.80.</li>
<li>Reliance Global Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/reli#NASDAQ">RELI</a>) declined 14% to $1.04.</li>
<li>SenesTech, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snes#NASDAQ">SNES</a>) fell 13.6% to $1.8738.</li>
<li>B. Riley Financial, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rily#NASDAQ">RILY</a>) dropped 11.2% to $18.61.</li>
<li>Puyi Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/puyi#NASDAQ">PUYI</a>) declined 10.8% to $3.53.</li>
<li>TMC the metals company Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tmc#NASDAQ">TMC</a>) fell 10% to $1.2595.</li>
<li>HUYA Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/huya#NYSE">HUYA</a>) fell 7.4% to $3.5650.</li>
<li>Fisker Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fsr#NYSE">FSR</a>) declined 6.7% to $2.08.</li>
<li>Chewy, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chwy#NYSE">CHWY</a>) fell 6.6% to $18.94.</li>
<li>Pagaya Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pgy#NASDAQ">PGY</a>) fell 5.8% to $1.29 after the company said Michael Kurlander, Chief Financial Officer, has stepped down from his role to pursue an outside opportunity. The company named Deputy Chief Financial Officer Evangelos Perros as Interim Chief Financial Officer.</li>
<li>Polaris Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pii#NYSE">PII</a>) fell 4% to $86.96.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/23/11/35959301/bitcoin-falls-below-37-000-blur-gas-among-top-losers"> Bitcoin Falls Below $37,000; Blur, Gas Among Top Losers</a>

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

AAOI

AFRM

APLM

ASST

AVXL

BDRX

BGLC

CAPT

CHWY

CLIR

HCWB

HUYA

INOD

IOBT

ITRN

MIRA

OXBR

PERF

PUYI

RDHL

RELI

RILY

SBET

SHOT

SNES

TCBP

THAR

VCXA

XENE

Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of US-listed Argentina stocks are trading higher following the election of libertarian presidential candidate Javier Milei.

U.S. stocks traded mostly lower, with the Dow Jones falling around 50 points on Monday.
Shares of Ituran Location and Control Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/itrn#NASDAQ">ITRN</a>) gained during Monday&rsquo;s session after the company reported third-quarter financial results.
The company posted quarterly earnings of 63 cents per share, up from 49 cents per share in the year-ago period. The company&rsquo;s quarterly sales rose 12% to $81.05 million.
Ituran Location and Control shares gained 11.3% to $27.69 on Monday.
Here are some other big stocks recording gains in today&rsquo;s session.
<ul>
<li>Affirm Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/afrm#NASDAQ">AFRM</a>) surged 13.7% to $29.82 following reports of record &#39;buy now, pay later&#39; predictions on Cyber Monday.</li>
<li>IRSA Inversiones y Representaciones Sociedad An&oacute;nima (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/irs#NYSE">IRS</a>) shares jumped 12.4% to $9.13.</li>
<li>EHang Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eh#NASDAQ">EH</a>) rose 12.1% to $19.71.</li>
<li>Xenon Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xene#NASDAQ">XENE</a>) surged 10.2% to $31.93 after the company announced topline results from the Phase 2 proof-of-concept X-NOVA clinical trial of XEN1101 in MDD.</li>
<li>Applied Optoelectronics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aaoi#NASDAQ">AAOI</a>) climbed 8.8% to $14.19.</li>
<li>Corporaci&oacute;n Am&eacute;rica Airports S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/caap#NYSE">CAAP</a>) rose 8.1% to $14.56.</li>
<li>Global-e Online Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/glbe#NASDAQ">GLBE</a>) climbed 7.4% to $33.95.</li>
<li>Telecom Argentina S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/teo#NYSE">TEO</a>) gained 6.7% to $8.26.</li>
<li>Grupo Financiero Galicia S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ggal#NASDAQ">GGAL</a>) rose 6.7% to $16.35.</li>
<li>DRDGOLD Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/drd#NYSE">DRD</a>) gained 5.8% to $9.19.</li>
<li>Roku, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/roku#NASDAQ">ROKU</a>) rose 5.8% to $100.51.</li>
<li>Crown Castle Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cci#NYSE">CCI</a>) rose 4.7% to $108.46 after activist fund Elliott took a $2 billion stake in the company and suggested operational improvements.</li>
<li>Teva Pharmaceutical Industries Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/teva#NYSE">TEVA</a>) gained 4.1% to $9.94 after UBS upgraded the stock from Neutral to Buy and raised its price target from $11 to $13.</li>
<li>Shopify Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/shop#NYSE">SHOP</a>) gained 4% to $73.20 after the company announced that Shopify merchants set a Black Friday record with a combined $4.1 billion in sales.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/23/11/35955917/goldman-sachs-verisign-and-2-other-stocks-insiders-are-selling"> Goldman Sachs, VeriSign And 2 Other Stocks Insiders Are Selling</a>

CAAP

GLBE

ROKU

SHOP

TEVA

Ituran Location and Control Posts Q3 Results, Joins Crown Castle, Shopify And Other Big Stocks Moving Higher On Monday

Shares of FLJ Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/flj#NASDAQ">FLJ</a>) shares jumped during Friday&rsquo;s session after the company announced it entered into a definitive agreement to acquire Alpha Mind Technology.
FLJ Group shares jumped 96.4% to $0.2123 on Friday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Versus Systems Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vs#NASDAQ">VS</a>) shares jumped 129.8% to $0.3816. Versus Systems announced a strategic investment from Cronus Equity Capital Group, LLC.</li>
<li>BioNexus Gene Lab Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bglc#NASDAQ">BGLC</a>) jumped 78% to $0.6596.</li>
<li>Quhuo Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qh#NASDAQ">QH</a>) gained 34% to $1.57.</li>
<li>iRobot Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/irbt#NASDAQ">IRBT</a>) gained 28.7% to $38.32. Amazon.com Inc.&rsquo;s (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amzn#NASDAQ">AMZN</a>) proposed acquisition of iRobot is reportedly on the verge of receiving unconditional approval from European Union antitrust authorities.</li>
<li>iClick Interactive Asia Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iclk#NASDAQ">ICLK</a>) climbed 25.7% to $3.77 after the company penned a merger deal with TSH Investment Holding and TSH Merger Sub Limited.</li>
<li>Captivision Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/capt#NASDAQ">CAPT</a>) gained 24% to $2.01.</li>
<li>Scilex Holding Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sclx#NASDAQ">SCLX</a>) climbed 22.7% to $1.24.</li>
<li>MMTec, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtc#NASDAQ">MTC</a>) shares climbed 19.3% to $1.17. The company recently reported a narrower loss for H1.</li>
<li>Gyre Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gyre#NASDAQ">GYRE</a>) gained 17.9% to $19.00.</li>
<li>Sight Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sght#NASDAQ">SGHT</a>) climbed 16.8% to $2.92.</li>
<li>Bruush Oral Care Inc.(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brsh#NASDAQ">BRSH</a>) rose 16.5% to $0.2970 after falling around 15% on Wednesday. On Nov. 15, Brush Oral Care received a notice from the Nasdaq Listing Qualifications Department that the company is currently not in compliance with the minimum bid price requirement because the closing bid price of BRSH shares was below $1.00 per share for a period of 30 consecutive business days.</li>
<li>Studio City International Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/msc#NYSE">MSC</a>) gained 14.8% to $5.64.</li>
<li>YPF Sociedad An&oacute;nima (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ypf#NYSE">YPF</a>) gained 14.1% to $17.11.</li>
<li>3D Systems Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ddd#NYSE">DDD</a>) climbed 13.5% to $5.26.</li>
<li>Banco Macro S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bma#NYSE">BMA</a>) gained 12.4% to $25.56. Banco Macro third-quarter net income declined 87% quarter-over-quarter.</li>
<li>IRSA Inversiones y Representaciones Sociedad An&oacute;nima (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/irs#NYSE">IRS</a>) gained 10.5% to $8.41.</li>
<li>Faraday Future Intelligent Electric Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ffie#NASDAQ">FFIE</a>) gained 9.6% to $0.5369 after the company announced its entry into the Middle East market by inking strategic cooperation agreements with Master Investment Group and Siraj Holding LLC.</li>
<li>bluebird bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blue#NASDAQ">BLUE</a>) rose 6.7% to $4.0450.</li>
<li>Nikola Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nkla#NASDAQ">NKLA</a>) climbed 6.4% to $1.00.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>LQR House Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lqr#NASDAQ">LQR</a>) fell 19.2% to $0.0332. LQR House received staff delisting determination from Nasdaq.</li>
<li>Impel Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/impl#NASDAQ">IMPL</a>) dipped 18.8% to $0.6325 after jumping 143% on Wednesday. Impel Pharmaceuticals recently announced exploration of strategic alternatives.</li>
<li>NexImmune, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nexi#NASDAQ">NEXI</a>) fell 17.5% to $2.93.</li>
<li>Cardio Diagnostics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdio#NASDAQ">CDIO</a>) shares fell 17.3% to $1.81. Cardio Diagnostics recently announced the publication of a study on the development and validation of PrecisionCHD in the Journal of the American Heart Association.</li>
<li>Cuentas Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cuen#NASDAQ">CUEN</a>) shares fell 14.4% to $1.1801 after declining 11% on Wednesday. Cuentas recently posted a narrower quarterly loss.</li>
<li>Asset Entities Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asst#NASDAQ">ASST</a>) fell 12.4% to $0.3218.</li>
<li>GDEV Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gdev#NASDAQ">GDEV</a>) fell 11.7% to $2.47. The company recently reported a decline in third-quarter sales.</li>
<li>Leap Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lptx#NASDAQ">LPTX</a>) declined 11.7% to $2.5250.</li>
<li>Rubicon Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rbt#NYSE">RBT</a>) fell 11.5% to $2.3430.</li>
<li>Newcourt Acquisition Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ncac#NASDAQ">NCAC</a>) declined 10.5% to $11.42.</li>
<li>Bitfarms Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bitf#NASDAQ">BITF</a>) fell 9.9% to $1.0450 after the company announced a C$60 million private placement with U.S. institutional investors.</li>
<li>Seelos Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/seel#NASDAQ">SEEL</a>) fell 7% to $0.1580 after jumping over 30% on Wednesday.</li>
<li>Intchains Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/icg#NASDAQ">ICG</a>) declined 5.6% to $8.34.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/23/11/35935872/how-to-earn-500-a-month-from-deere-stock-following-upbeat-earnings"> How To Earn $500 A Month From Deere Stock Following Upbeat Earnings</a>

AMZN

BITF

BLUE

BRSH

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

CUEN

FFIE

GDEV

GYRE

ICLK

IMPL

IRBT

LPTX

NCAC

NEXI

NKLA

SCLX

SEEL

SGHT

Why FLJ Group Shares Are Trading Higher By Around 96%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of ReNew Energy Global Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rnw#NASDAQ">RNW</a>) gained during Monday&rsquo;s session following strong quarterly sales.
ReNew Energy Global posted quarterly sales of $345.00 million, topping market estimates of $258.41 million.
ReNew Energy raised its FY24 adjusted EBITDA guidance to INR 62 billion - INR 66 billion.
ReNew Energy Global gained 13.6% to $6.74 on Monday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Bruush Oral Care Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brsh#NASDAQ">BRSH</a>) shares jumped 147.2% to $0.4179. Br&uuml;ush received Nasdaq notification regarding minimum bid requirements.</li>
<li>Cuentas Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cuen#NASDAQ">CUEN</a>) shares gained 59% to $1.5098 after reporting a narrower quarterly loss.</li>
<li>Altamira Therapeutics Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cyto#NASDAQ">CYTO</a>) jumped 52% to $0.4280. Altamira Therapeutics recently entered into a binding agreement for the sale of a 51% stake in its subsidiary Altamira Medica AG.</li>
<li>Cardio Diagnostics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdio#NASDAQ">CDIO</a>) gained 41.4% to $1.4000. Cardio Diagnostics Holdings announced the publication of its study in the Journal of the American Heart Association (JAHA), an official journal of the American Heart Association.</li>
<li>YPF Sociedad An&oacute;nima (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ypf#NYSE">YPF</a>) shares climbed 40.8% to $15.11. Javier Milei&lsquo;s victory in Argentina&rsquo;s presidential election sparked a rally in Argentine ADRs trading on major U.S. stock exchanges.</li>
<li>GD Culture Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gdc#NASDAQ">GDC</a>) rose 26.8% to $4.3074. GD Culture Group unveiled its transformative and photorealistic AI-driven digital human technology on TikTok.</li>
<li>Blue Star Foods Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bsfc#NASDAQ">BSFC</a>) shares gained 26.8% to $0.1752 after jumping 18% on Friday. Blue Star Foods recently signed a 2-year bid award purchase agreement with Sysco Corporation.</li>
<li>MIRA Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mira#NASDAQ">MIRA</a>) gained 25.3% to $4.2729. MIRA Pharmaceuticals announced exclusive licensing agreement for oral ketamine analog, Ketamir-2.</li>
<li>Grupo Financiero Galicia S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ggal#NASDAQ">GGAL</a>) rose 25% to $15.63 after gaining 5% on Friday.</li>
<li>Transportadora de Gas del Sur S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tgs#NYSE">TGS</a>) shares climbed 23.1% to $12.88 after gaining over 4% on Friday.</li>
<li>Central Puerto S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cepu#NYSE">CEPU</a>) climbed 23.1% to $7.58.</li>
<li>Pampa Energ&iacute;a S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pam#NYSE">PAM</a>) gained 23% to $45.60.</li>
<li>Transportadora de Gas del Sur S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tgs#NYSE">TGS</a>) rose 22.6% to $12.82 after gaining over 4% on Friday.</li>
<li>Banco BBVA Argentina S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bbar#NYSE">BBAR</a>) gained 22.4% to $5.40.</li>
<li>LogicMark, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lgmk#NASDAQ">LGMK</a>) shares rose 22.2% to $2.04. LogicMark recently posted GAAP loss of $1.10 per share for the third quarter.</li>
<li>IRSA Inversiones y Representaciones Sociedad An&oacute;nima (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/irs#NYSE">IRS</a>) gained 20.3% to $7.79.</li>
<li>Telecom Argentina S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/teo#NYSE">TEO</a>) climbed 19.4% to $6.40 after gaining around 4% on Friday.</li>
<li>Banco Macro S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bma#NYSE">BMA</a>) gained 17.1% to $23.71.</li>
<li>HireRight Holdings Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hrt#NYSE">HRT</a>) jumped 17.4% to $11.81 after gaining 5% on Friday.</li>
<li>Yoshiharu Global Co. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/yosh#NASDAQ">YOSH</a>) shares climbed 15.7% to $0.4050. The company recently reported an increase in quarterly sales.</li>
<li>Gyre Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gyre#NASDAQ">GYRE</a>) gained 15.6% to $17.00.</li>
<li>MediciNova, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnov#NASDAQ">MNOV</a>) rose 15.2% to $2.0508. The company announced new data and results of a Phase 2 clinical trial of MN-166 (ibudilast) in glioblastoma presented at the 28th Annual Meeting of the Society for Neuro-Oncology.</li>
<li>Kronos Bio, Inc.(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kron#NASDAQ">KRON</a>) gained 14.4% to $1.2699. Kronos recently posted downbeat quarterly results.</li>
<li>Loma Negra Compa&ntilde;&iacute;a Industrial Argentina Sociedad An&oacute;nima (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/loma#NYSE">LOMA</a>) gained 14.4% to $6.80.</li>
<li>Iovance Biotherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iova#NASDAQ">IOVA</a>) rose 13.6% to $5.74. Goldman Sachs initiated coverage on Iovance Biotherapeutics with a Buy rating and announced a price target of $12.</li>
<li>Anavex Life Sciences Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avxl#NASDAQ">AVXL</a>) jumped 11.8% to $7.01. The clinical-stage biopharmaceutical company announced that it initiated a regulatory submission with the European Medicines Agency (EMA).</li>
<li>Intellia Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ntla#NASDAQ">NTLA</a>) rose 11.7% to $31.42. Intellia Therapeutics recently announced it received European Union orphan drug designation for NTLA-2002.</li>
<li>XPeng Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xpev#NYSE">XPEV</a>) gained 9% to $18.30.</li>
<li>Motus GI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mots#NASDAQ">MOTS</a>) gained 7.6% to $3.98 after declining around 5% on Friday. Motus GI recently announced the Pure-Vu EVS Gastro was successfully used in the first procedure since receiving FDA clearance.</li>
<li>NIO Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nio#NYSE">NIO</a>) fell 6.2% to $7.85. Nio announced on Sunday that it has activated its 2,100th power swap station.</li>
<li>Coinbase Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coin#NASDAQ">COIN</a>) gained 4.2% to $103.12.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>NanoString Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nstg#NASDAQ">NSTG</a>) shares fell 46% to $0.69. TD Cowen downgraded NanoString Technologies from Outperform to Market Perform and lowered the price target from $6 to $1.4.</li>
<li>PaxMedica, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pxmd#NASDAQ">PXMD</a>) fell 40.6% to $1.04 after the company announced pricing of $7 million public offering of 5,384,615 shares and accompanying warrants at a price of $1.30 per unit.</li>
<li>Safe and Green Development Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgd#NASDAQ">SGD</a>) fell 25.5% to $3.14. Safe And Green Development shares jumped 39% on Friday after the company said it does not intend to conduct the offering of the shares of common stock contemplated by the Registration Statement.</li>
<li>Alzamend Neuro, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alzn#NASDAQ">ALZN</a>) dipped 25% to $1.2400. Alzamend Neuro received a &quot;Study May Proceed&quot; letter from the FDA for the initiation of study AL001-MDD01, a Phase 2A clinical study of AL001 for major depressive disorder (MDD).</li>
<li>Yatsen Holding Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ysg#NYSE">YSG</a>) fell 24.2% to $0.6559. Yatsen Holding is expected to release its unaudited financial results for the third quarter on Nov. 21, 2023.</li>
<li>2seventy bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsvt#NASDAQ">TSVT</a>) declined 16.4% to $1.78. The FDA&#39;s Oncologic Drugs Advisory Committee (ODAC) will meet to review data supporting the supplemental Biologics License Application (sBLA) for Abecma (idecabtagene vicleucel) for earlier lines of triple-class exposed relapsed or refractory multiple myeloma (RRMM) based on results from the pivotal Phase 3 KarMMa-3 study.</li>
<li>Allurion Technologies Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/alur#NYSE">ALUR</a>) fell 12.6% to $3.72.</li>
<li>Safe &amp; Green Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgbx#NASDAQ">SGBX</a>) shares fell 12.6% to $0.6821 after gaining around 7% on Friday. Safe &amp; Green Holdings recently posted a narrower-than-expected quarterly loss.</li>
<li>Greenland Technologies Holding Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gtec#NASDAQ">GTEC</a>) declined 12.5% to $2.87 following weak quarterly results.</li>
<li>reAlpha Tech Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aire#NASDAQ">AIRE</a>) declined 10.5% to $8.40. ReAlpha Tech filed a prospectus for the offering of up to 1.67 million common units at a price of $12 per unit.</li>
<li>Applied UV, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/auvi#NASDAQ">AUVI</a>) shares fell 9.4% to $0.1340 after the company reported third-quarter results.</li>
<li>MGO Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgol#NASDAQ">MGOL</a>) shares fell 9.1% to $0.50 after jumping over 10% on Friday. MGO Global recently posted a wider third-quarter loss.</li>
<li>Genelux Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gnlx#NASDAQ">GNLX</a>) declined 8.7% to $10.83.</li>
<li>Tharimmune, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/thar#NASDAQ">THAR</a>) shares fell 8.6% to $0.1922. Tharimmune shares climbed around 17% on Friday after the company announced a 1-for-25 reverse stock split.</li>
<li>Chegg, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chgg#NYSE">CHGG</a>) fell 8.2% to $9.60. Morgan Stanley downgraded Chegg from Equal-Weight to Underweight and lowered the price target from $10 to $9.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/11/35870052/this-analyst-with-84-accuracy-rate-sees-around-22-upside-in-nvidia-here-are-5-stock-pick"> This Analyst With 84% Accuracy Rate Sees Around 22% Upside In NVIDIA - Here Are 5 Stock Picks For Last Week From Wall Street&#39;s Most Accurate Analysts</a>

AIRE

ALUR

ALZN

AUVI

BSFC

COIN

CYTO

GNLX

GTEC

IOVA

KRON

LGMK

MGOL

MNOV

MOTS

NSTG

NTLA

PXMD

SGBX

TSVT

XPEV

YOSH

Why ReNew Energy Global Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session

BBVA

<h3>The Meaning Behind Value Stocks</h3>
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock. 
<h2>The following stocks are considered to be notable value stocks in the real estate sector:</h2>
<ol>
<li>Transcontinental Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TCI#NYSE">TCI</a>) - P/E: 0.59</li>
<li>Franklin BSP Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FBRT#NYSE">FBRT</a>) - P/E: 8.26</li>
<li>IRSA Inversiones y (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IRS#NYSE">IRS</a>) - P/E: 5.23</li>
<li>Forestar Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOR#NYSE">FOR</a>) - P/E: 9.35</li>
<li>Rithm Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RITM#NYSE">RITM</a>) - P/E: 7.63</li>
</ol>
Most recently, Transcontinental Realty reported earnings per share at $0.06, whereas in Q1 earnings per share sat at $0.41. This quarter, Franklin BSP Realty Trust experienced an increase in earnings per share, which was $0.44 in Q1 and is now $0.66. The company's most recent dividend yield sits at 10.0%, which has increased by 0.1% from 9.9% last quarter. 
This quarter, IRSA Inversiones y experienced an increase in earnings per share, which was $0.92 in Q3 and is now $1.38. Forestar Group's earnings per share for Q3 sits at $0.93, whereas in Q2, they were at 0.54. Rithm Capital has reported Q2 earnings per share at $0.62, which has increased by 77.14% compared to Q1, which was 0.35. The company's most recent dividend yield sits at 10.05%, which has decreased by 0.77% from 10.82% last quarter. 
These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.

FBRT

Dividends

IRSA Says On September 5, 2023, The Board Of Directors Called A Shareholders' Meeting In Order To Distribute A Dividend For The Sum Up To ARS 64,000 Million, Among Other Points To Be Discussed

Press Releases

Real Estate

IRSA Inversiones y Representaciones S.A. (NYSE: IRS; BYMA: IRSA), the leading real estate company in Argentina, announces today its results for the third quarter of the Fiscal Year 2024 ended March 31, 2024

IRSA Inversiones y Representaciones S.A. announces its results for Fiscal Year 2024, ended June 30, 2024

IRSA Inversiones y Representaciones S.A. Announces that it has filed its 20-F Form for FY 2024 ended June 30, 2024

IRSA Inversiones y Representaciones S.A announces its results for the first quarter of Fiscal Year 2025 ended September 30, 2024

IRSA Inversiones y Representaciones S.A announces its results for the second quarter of Fiscal Year 2025 ended December 31, 2024

Offerings

IRSA Announces Commencement of Exchange Offer for Any and All of its 8.750% Senior Notes due 2028

ARGENTA WELCOMES ARGENTINE BUSINESSMAN EDUARDO ELSZTAIN AS STRATEGIC INVESTOR THROUGH CAD$5 MILLION PRIVATE PLACEMENT

TSXV:AGAG

Avalon Globocare

American Realty Investors, Inc. Common Stock

American Realty Investors

CKX Lands

FRP Holdings

New Concept Energy

Gyrodyne

The Intergroup Corporation - Common Stock

Intergroup

Kennedy-Wilson Holdings Inc. Common Stock

Kennedy-Wilson Holdings

LandBridge Company LLC Class A Shares Representing Limited Liability Company Interests

LandBridge

Logistic Properties of the Americas Ordinary Shares

Logistic Properties

Maui Land & Pineapple Company, Inc. Common Stock

Maui Land & Pineapple Co

Murano Global Investments PLC - Ordinary Shares

Murano Global Investments

American Strategic Investment Co. Class A Common Stock

American Strategic

Belpointe PREP

Rafael Holdings, Inc. Class B Common Stock

Rafael Holdings

Reitar Logtech Holdings Limited - Ordinary shares

Reitar Logtech Holdings

Comments

IRSA Inversiones y

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO